Attached files
file | filename |
---|---|
EX-4.1 - EXHIBIT 4.1 DESCRIPTION OF CAPITAL STOCK - VOLITIONRX LTD | f10k123119_ex4z1.htm |
10-K - FORM 10-K ANNUAL REPORT - VOLITIONRX LTD | f10k123119_10k.htm |
EX-31.2 - EXHIBIT 31.2 SECTION 302 CERTIFICATION - VOLITIONRX LTD | f10k123119_ex31z2.htm |
EX-31.1 - EXHIBIT 31.1 SECTION 302 CERTIFICATION - VOLITIONRX LTD | f10k123119_ex31z1.htm |
EX-23.1 - EXHIBIT 23.1 AUDITOR'S CONSENT - VOLITIONRX LTD | f10k123119_ex23z1.htm |
EX-21.1 - EXHIBIT 21.1 SUBSIDIARIES OF VOLITIONRX LIMITED - VOLITIONRX LTD | f10k123119_ex21z1.htm |
EX-10.22 - EXHIBIT 10.22 AMENDMENT NO. 1 TO CLINICAL STUDY AGREEMENT - VOLITIONRX LTD | f10k123119_ex10z22.htm |
EXHIBIT 32.1
CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The following certifications are hereby made in connection with the Annual Report on Form 10-K of VolitionRx Limited (the “Company”) for the period ended December 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”):
I, Cameron Reynolds, President and Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, (i) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods presented.
Date: February 20, 2020By:/s/ Cameron Reynolds
Cameron Reynolds
President and Chief Executive Officer
I, David Vanston, Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, (i) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods presented.
Date: February 20, 2020By:/s/ David Vanston
David Vanston
Chief Financial Officer and Treasurer